NasdaqCM - Nasdaq Real Time Price USD
Monopar Therapeutics Inc. (MNPR)
41.92
+0.44
+(1.07%)
As of 10:34:43 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-6,404.14
-6,404.14
-7,858.29
-7,228.56
-7,317.40
Investing Cash Flow
-14,338.40
-14,338.40
4,927.75
-4,918.51
--
Financing Cash Flow
59,292.26
59,292.26
2,027.23
32.87
10,879.54
End Cash Position
45,816.29
45,816.29
7,266.08
8,186.19
20,303.87
Issuance of Capital Stock
59,396.39
59,396.39
2,074.20
109.34
10,925.31
Free Cash Flow
-6,404.14
-6,404.14
-7,858.29
-7,228.56
-7,317.40
12/31/2021 - 12/19/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRUG Bright Minds Biosciences Inc.
34.00
-0.29%
CALC CalciMedica, Inc.
1.4811
-3.20%
NMRA Neumora Therapeutics, Inc.
0.7453
+4.84%
AARD Aardvark Therapeutics, Inc. Common Stock
8.35
-2.00%
BCYC Bicycle Therapeutics plc
8.70
+0.35%
IDYA IDEAYA Biosciences, Inc.
19.00
+0.96%
XLO Xilio Therapeutics, Inc.
0.8299
+4.54%
TRVI Trevi Therapeutics, Inc.
6.25
-0.32%
TRAW Traws Pharma, Inc.
1.5200
+3.40%
INZY Inozyme Pharma, Inc.
0.9951
+1.49%